In Vivo Beta-Cell Imaging with VMAT 2 Ligands - Current State-of-the-Art and Future Perspectives

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|14|1568-1581

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.14, 2010-05, pp. : 1568-1581

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives

By  

Current Pharmaceutical Design, Vol. 21, Iss. 36, 2015-11 ,pp. : 5233-5244

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclometalated Complexes of Platinum and Gold with Biological Properties: State-of-the-Art and Future Perspectives

By  

Current Medicinal Chemistry, Vol. 25, Iss. 4, 2018-02 ,pp. : 437-461

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy in Liver Diseases: State-of-the-Art and Future Perspectives

By  

Current Gene Therapy, Vol. 12, Iss. 6, 2012-12 ,pp. : 463-483

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Radiotracers for the Determination of the Beta-Cell Mass In Vivo

By  

Current Pharmaceutical Design, Vol. 16, Iss. 14, 2010-05 ,pp. : 1561-1567

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical PET Imaging of Insulinoma and Beta-Cell Hyperplasia

By  

Current Pharmaceutical Design, Vol. 16, Iss. 14, 2010-05 ,pp. : 1550-1560

Bentham Science Publishers

Access to resources Recommend Favorite